Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» funding
funding
No strings attached: COVID-19 pandemic raises profile of non-dilutive funding for life science companies
No strings attached: COVID-19 pandemic raises profile of non-dilutive funding for life science companies
Biopharma Reporter
vaccines
COVID-19
funding
non-dilutive funding
government funding
Flag link:
Beam, Verve stockpile cash as investors bank on gene editing progress
Beam, Verve stockpile cash as investors bank on gene editing progress
BioPharma Dive
Beam Therapeutics
Verve Therapeutics
gene editing
funding
Flag link:
Dana-Farber launches venture fund targeting incurable cancers
Dana-Farber launches venture fund targeting incurable cancers
BioPharma Dive
Dana-Farber
cancer
venture capital
funding
Flag link:
Two Cancer Companies Close Series A Rounds Netting $144 Million
Two Cancer Companies Close Series A Rounds Netting $144 Million
BioSpace
cancer
oncology
funding
Delfi Diagnostics
Elucida Oncology
Flag link:
Pfizer invests $120M in 4 biotechs through new growth fund
Pfizer invests $120M in 4 biotechs through new growth fund
Fierce Biotech
Pfizer
funding
PBGI
Homology Medicines
Essa Pharma
Vedanta Biosciences
Trillium Therapeutics
Flag link:
Eli Lilly Partners with Blacksmith Medicines in $300 Million Seed Funding Deal
Eli Lilly Partners with Blacksmith Medicines in $300 Million Seed Funding Deal
BioSpace
Eli Lilly
Blacksmith Medicines
funding
metalloenzyme targets
Flag link:
Buoyed by renewed clamor for infectious disease R&D, Affinivax nabs huge $226M funding round
Buoyed by renewed clamor for infectious disease R&D, Affinivax nabs huge $226M funding round
Fierce Biotech
COVID-19
Affinivax
vaccines
funding
Flag link:
Covid or not, venture financing breaks records
Covid or not, venture financing breaks records
EP Vantage
venture financing
funding
Flag link:
Two Companies Ring in 2021 with Cash for Cancer and Rare Diseases
Two Companies Ring in 2021 with Cash for Cancer and Rare Diseases
BioSpace
funding
biotech
IconOVir Bio
oncolytic viruses
cancer
oncology
Aro Biotherapeutics
RNA
Flag link:
Ikena bags $120M to advance growing pipeline of cancer drugs
Ikena bags $120M to advance growing pipeline of cancer drugs
Fierce Biotech
Ikena Oncology
cancer
oncology
funding
Flag link:
Vivace Therapeutics scores $30M Series C to take oncology candidate for 'Hippo' pathway to human trial next year
Vivace Therapeutics scores $30M Series C to take oncology candidate for 'Hippo' pathway to human trial next year
Endpoints
Vivace Therapeutics
oncology
hippo pathway
funding
Flag link:
Locanabio Raises $100 Million to Advance RNA-Targeted Gene Therapies
Locanabio Raises $100 Million to Advance RNA-Targeted Gene Therapies
BioSpace
Locanbio
RNA
gene therapies
funding
Flag link:
Oncolytic immunotherapy biotech CG Oncology nabs $47M round for late-stage cancer push
Oncolytic immunotherapy biotech CG Oncology nabs $47M round for late-stage cancer push
Fierce Biotech
CG Oncology
Oncolytics
funding
Flag link:
Vigil Neuroscience launches with a $50M Series A and two former Amgen neuroscience candidates
Vigil Neuroscience launches with a $50M Series A and two former Amgen neuroscience candidates
Endpoints
Vigil Neuroscience
funding
Amgen
Neurosciences
Flag link:
Catamaran Bio sails into the CAR-NK waters with a $42M launch round
Catamaran Bio sails into the CAR-NK waters with a $42M launch round
Endpoints
Catamaran Bio
CAR-NK
funding
natural killer cells
Flag link:
Bayer provides funding to five more digital health start-ups
Bayer provides funding to five more digital health start-ups
Pharmaforum
Bayer
digital health
funding
G4A
Flag link:
October sees boost for biotech funding
October sees boost for biotech funding
Biopharma Reporter
funding
biotech
Flag link:
Novartis alums Jimenez, Fishman unveil their next act: Aditum Bio
Novartis alums Jimenez, Fishman unveil their next act: Aditum Bio
Fierce Biotech
Joe Jimenez
Novartis
Aditum Bio
biotech
funding
Flag link:
MD Anderson establishes new $50M+ biotech fund to choose the next promising cancer therapies
MD Anderson establishes new $50M+ biotech fund to choose the next promising cancer therapies
Endpoints
MD Anderson
biotech
funding
cancer
oncology
Flag link:
5 Hot Trends in Wearable Medical Devices
5 Hot Trends in Wearable Medical Devices
Medical Devices and Diagnostics Industry
devices
wearables
regulatory
FDA
wellness
COVID-19
pandemic
funding
digital health
Flag link:
Pages
1
2
3
4
5
6
7
8
9
next ›
last »